Answer
Combining rasagiline tartrate with buprenorphine-containing medicines increases the risk of potentially life-threatening serotonin syndrome, so co-administration requires caution.
Sources for this answer
- Rasagiline Milpharm 1 mg tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked